Search

everythinglearnresearchcommunity

for

Search:↓

Nanotechnology in dermatology shows promise for better drug delivery and treatment effectiveness but requires more safety research.

Drugs targeting the JAK/STAT pathway can improve atopic dermatitis but vary in effectiveness for vitiligo and alopecia areata, with generally mild safety concerns.

Dupilumab is being tested for many new skin, respiratory, and gastrointestinal conditions.

Toxic epidermal necrolysis is a severe skin reaction often linked to drugs, requiring careful medication use and supportive care.

JAK inhibitors show promise for treating skin and hair disorders but need more research on long-term safety and effectiveness.

Bee venom might be a good alternative treatment for various skin conditions because it has many healing properties.

Early detection and stopping the drug are key to managing DRESS, and careful monitoring is important due to possible severe reactions.

Skin problems like acne, dry skin, and nail and hair changes are common in patients taking EGFR inhibitors.

Tofacitinib citrate is effective for moderate-to-severe chronic plaque psoriasis but has safety concerns at higher doses.

Most pregnant women experience skin changes like darkening and stretch marks, and some may have skin conditions that usually get better after giving birth.

Capecitabine is as effective as intravenous treatments with fewer side effects, but requires careful management of Hand-foot syndrome and patient education.

Psychotropic medications can cause skin reactions, including severe conditions like SJS and TEN, and it's important for psychiatrists to recognize and manage these side effects.

The document provides advice on how to recognize and treat skin-related side effects of cancer drugs known as EGFR inhibitors.

Female donor to male recipient sex mismatch and positive ACA-IgG are key risk factors for vitiligo and alopecia areata in chronic GvHD patients.

Spanish experts provided guidelines for treating skin side effects in cancer patients on new therapies, stressing early action and teamwork.

Some treatments like methotrexate with prednisone might help juvenile morphea, but more research is needed to confirm.

Scientists made safflower seeds produce a human growth factor that could help with hair growth and wound healing.

New chemotherapy drugs cause skin side effects, but treatments like minocycline and tetracycline can help reduce them.

Severe digestive issues in DRESS need early endoscopy for better treatment.

Some alternative vitiligo treatments show promise, but none are as effective as psoralens and UVA.

Some anticonvulsant drugs can cause skin reactions, ranging from mild to severe, and managing these reactions is important for patient care.

Different monkey species in a lab showed varying levels of hair loss due to factors like type, sex, age, season, and living conditions.

The new FDA labeling rules provide more detailed drug safety information for pregnant and breastfeeding women, but more data is needed on the risks of many dermatologic drugs.

A woman with severe angioedema improved significantly after treatment with rituximab.

Dermatologists play a key role in identifying and documenting signs of abuse and injury for forensic investigations.

Cell therapy shows promise for treating severe psoriasis but needs more research to confirm safety and effectiveness.

Scalp involvement is common in pemphigus and can lead to hair loss, with the severity of scalp lesions linked to overall disease severity.

Stopping adalimumab and starting methotrexate with topical treatments improved the woman's scalp psoriasis and hair regrew.

A young woman had a rare skin reaction to a medication for her joint disease, and a combination therapy improved her condition.

A rare scalp disease causes hair loss, pus-filled nodules, and scarring.